# Import Alert 66-66: APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122

**Compliance Urgency Score:** 35/100

| Field | Value |
|---|---|
| Alert number | 66-66 |
| Name | APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122 |
| Industry | Drugs & biologics |
| Type | DWPE |
| Last published | 2024-10-22 |

## Why this score
- Detention without physical examination.

Source: U.S. FDA Import Alerts (accessdata.fda.gov) (https://www.accessdata.fda.gov/cms_ia/importalert_202.html). Last refreshed: 2026-11-04T21:41:37.385Z.
From FDA's published import alert list; the FDA alert page (linked) is authoritative and lists the firms and products covered. Informational only, not regulatory advice.